Lear's fair value estimate has been reset higher, moving from about US$127.64 to about US$139.55 per share, as recent research firms factor in updated revenue growth assumptions from about 1.78% to ...
TrumpRx is the White House’s new drug pricing website. Here’s what it does, why markets—including crypto—are watching.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果